πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,494 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10927349

Platform for generating safe cell therapeutics

The Regents of the University of California Β· Granted Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10927160

Engineered invariant natural killer T (iNKT) cells and methods of making and using thereof

The Regents of the University of California Β· Granted Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10927165

Antibodies that neutralize botulinum neurotoxins

The Regents of the University of California Β· Granted Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10925975

Acidic nanoparticles for restoration of autophagy

The Regents of the University of California Β· Granted Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10925972

Glycan-dependent immunotherapeutic molecules

The Regents of the University of California Β· Granted Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10918738

Method of treating type I diabetes using an AAV vector encoding uracortin 2

The Regents of the University of California Β· Granted Tue Feb 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10920190

Folding biological tissue via programmed cellular contractility

The Regents of the University of California Β· Granted Tue Feb 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10918703

Fusion proteins for treating inflammatory diseases

The Regents of the University of California Β· Granted Tue Feb 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10919932

Bi-terminal pegylated integrin-binding peptides and methods of use thereof

The Regents of the University of California Β· Granted Tue Feb 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10918598

On demand vesicle formation from vesicle precursors suitable for long-term storage

The Regents of the University of California Β· Granted Tue Feb 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10918648

Estrogen receptor modulator combinations

The Regents of the University of California Β· Granted Tue Feb 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10918653

Bovine milk oligosaccharides

The Regents of the University of California Β· Granted Tue Feb 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10918594

Controlled-release CNS modulating compositions and methods for the treatment of otic disor

The Regents of the University of California Β· Granted Tue Feb 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10913798

Modulators of ROR1-ROR2 binding

The Regents of the University of California Β· Granted Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10913750

Tubulin-binding compounds, compositions and uses related thereto

The Regents of the University of California Β· Granted Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10913726

Centrally active and orally bioavailable antidotes for organophosphate exposure and method

The Regents of the University of California Β· Granted Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10912933

Implants for localized drug delivery and methods of use thereof

The Regents of the University of California Β· Granted Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10913957

Genetically modified MSC and therapeutic methods

The Regents of the University of California Β· Granted Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10912860

Controllable self-annealing microgel particles for biomedical applications

The Regents of the University of California Β· Granted Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10912764

Salinosporamides and methods of use thereof

The Regents of the University of California Β· Granted Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10912834

Topical formulations based on ionic species for skin treatment

The Regents of the University of California Β· Granted Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10905736

Ezetimibe-associated ApoA-I mimetic peptides showing enhanced synergism

The Regents of the University of California Β· Granted Tue Feb 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10907124

Biomimetic membranes, methods of manufacture and uses thereof

The Regents of the University of California Β· Granted Tue Feb 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10900973

Therapeutic antibodies against ROR-1 protein and methods for use of same

The Regents of the University of California Β· Granted Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted